Skip to main content
. 2018 Apr 23;2018(4):CD011006. doi: 10.1002/14651858.CD011006.pub3

N0405078066.

Methods Randomised controlled trial
Participants People with lung cancer
Interventions Venlafaxine versus placebo
Outcomes Effects on symptom profiles after 12 weeks (not clearly specified)
Notes According to the protocol the study has been completed, but no published or unpublished data have been retrieved. Not clear if the study is eligible. Authors did not reply to our request for clarification and for data.